WealthShield Partners’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

WealthShield Partners’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,650	Closed	-$7K	–	281
2018 Q2	$7K	Hold	1,650	–	–	﹤0.01%	208
2018 Q1	$9K	Hold	1,650	–	–	0.01%	199
2017 Q4	$14K	Buy	+1,650	New	+$15K	0.01%	188

Other funds holding IPCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

WealthShield Partners's IPCI Position: Q3 2018 in Review

WealthShield Partners sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1,650 shares — an estimated $7K sold.

WealthShield Partners first reported a position in IPCI in Q4 2017 and held it in 3 quarters. The position peaked at $14K in Q4 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

WealthShield Partners reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
WealthShield Partners sold 1,650 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $7K.
WealthShield Partners first reported a position in Intellipharmaceuticals International Inc. in Q4 2017 and held it in 3 quarters.
WealthShield Partners's Intellipharmaceuticals International Inc. position peaked at $14K in Q4 2017.
10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on WealthShield Partners's 13F filing for Q3 2018, filed 5 Nov 2018.